With a background in chemistry and biotechnology, Sherri L. Oslick counsels clients on intellectual property strategies for a broad range of technologies within the life sciences industry. Dr. Oslick’s background in research and dual focus in both biotech and chemistry offers her a unique perspective and broader understanding of her client’s innovative technologies.  

Using her science-based perspective and previous litigation experience, Dr. Oslick prosecutes patents for life sciences companies looking to protect their new innovations. Dr. Oslick’s graduate and post-doctoral research in chemistry and biochemistry and molecular biology allows her to easily communicate and understand complex inventions in the biotech and pharma industries.  

Prior to joining the firm, Dr. Oslick spent time in research at the University of Chicago. She joined MBHB as a technical advisor and worked at the firm full-time while earning her law degree, allowing her to gain practical experience while developing knowledge to help her clients.  

Her interdisciplinary knowledge in biotechnology and chemistry and her level of experience in the legal field allows Dr. Oslick to effectively advise, counsel, and retain hands-on time with clients across the biotech and chemistry spaces. Outside of the firm, Dr. Oslick is an animal lover who enjoys competing in dog sports with her rescue dogs.  

• Secured patent protection for clients in a broad range of technologies, for example, small molecule therapeutics, antibodies, chemical processes and therapeutic methods.
• Managed and prosecuted patent portfolios for clients including individual inventors, startups, Fortune 500 companies, nonprofit organizations and governmental agencies.
• Counseled startup and early-stage clients on freedom to operate, validity, infringement, and patentability for a wide range of technologies.
• Helped a non-profit research institute develop a global portfolio of patents.
• Supported a leading pharmaceutical company in all facets of patent litigation, including a jury trial.

• NIH Individual NRSA Postdoctoral Fellowship